• Journal of Veterinary Clinics
• /
• v.15 no.2
• /
• pp.410-416
• /
• 1998

These experiments were designed to evaluate the possibility of brain-stem auditory evoked responses(BAER) as a diagnostic tool for deafness in dogs. The BAER was recorded from three different groups of dogs; the normal dogs,'dog with otitis externa and dogs with unilateral destruction of cochlear. BAER of the normal dogs was consisted of distinct five peaks(I, II, III-IV, V). Furthermore, the clear shapes of waveform were observed at 85 dB. The latency of BAER was increased with reducing the intensity of sound-stimulus. The highest threshold of BAER was measured at 2 KHz with 10-30 dB. Dog with otitis externs demonstrated unclear shapes of BAER compared to the that of normal dogs. In the dogs with unilateral destruction of cochlear, the flat and indistinct waveform of BAER was recorded from the cochlear destroyed ear while that of BAER from normal side of ears did not show any differences from the normal BAER. These results indicate that the BAER can be clinically used in order to diagnose the deafness in dogs.

• Journal of Biomedical Engineering Research
• /
• v.3 no.2
• /
• pp.105-112
• /
• 1982

Using electronic cochlear implant system, we studied in cats the difference in the response of the brain stem evoked response (BER) during the stimulation with the acoustic signals and the electric signals. These brain stem electric responses were analyzed using the integral pulse frequency modulation method of the auditory nervous system. Animal experimental results and the analysis show that the carrier wave hasimprored the frequency specificity. of the electronic auditory prosthesis.

• Journal of Audiology & Otology
• /
• v.24 no.1
• /
• pp.10-16
• /
• 2020

Background and Objectives:The blockage of adenosine receptors by caffeine changes the levels of neurotransmitters. These receptors are present in all parts of the body, including the auditory and vestibular systems. This study aimed to evaluate the effect of caffeine on evoked potentials using auditory brainstem responses (ABRs) and cervical vestibular-evoked myogenic potentials (cVEMPs) in a double-blind placebo-controlled study. Subjects and Methods: Forty individuals (20 females and 20 males; aged 18-25 years) were randomly assigned to two groups: the test group (consuming 3 mg/kg pure caffeine powder with little sugar and dry milk in 100 mL of water), and the placebo group (consuming only sugar and dry milk in 100 mL water as placebo). The cVEMPs and ABRs were recorded before and after caffeine or placebo intake. Results: A significant difference was observed in the absolute latencies of I and III (p<0.010), and V (p<0.001) and in the inter-peak latencies of III-V and I-V (p<0.001) of ABRs wave. In contrast, no significant difference was found in cVEMP parameters (P13 and N23 latency, threshold, P13-N23 amplitude, and amplitude ratio). The mean amplitudes of P13-N23 showed an increase after caffeine ingestion. However, this was not significant compared with the placebo group (p>0.050). Conclusions: It seems that the extent of caffeine's effects varies for differently evoked potentials. Latency reduction in ABRs indicates that caffeine improves transmission in the central brain auditory pathways. However, different effects of caffeine on auditory- and vestibular-evoked potentials could be attributed to the differences in sensitivities of the ABR and cVEMP tests.

• Korean Journal of Audiology
• /
• v.24 no.1
• /
• pp.10-16
• /
• 2020

Background and Objectives:The blockage of adenosine receptors by caffeine changes the levels of neurotransmitters. These receptors are present in all parts of the body, including the auditory and vestibular systems. This study aimed to evaluate the effect of caffeine on evoked potentials using auditory brainstem responses (ABRs) and cervical vestibular-evoked myogenic potentials (cVEMPs) in a double-blind placebo-controlled study. Subjects and Methods: Forty individuals (20 females and 20 males; aged 18-25 years) were randomly assigned to two groups: the test group (consuming 3 mg/kg pure caffeine powder with little sugar and dry milk in 100 mL of water), and the placebo group (consuming only sugar and dry milk in 100 mL water as placebo). The cVEMPs and ABRs were recorded before and after caffeine or placebo intake. Results: A significant difference was observed in the absolute latencies of I and III (p<0.010), and V (p<0.001) and in the inter-peak latencies of III-V and I-V (p<0.001) of ABRs wave. In contrast, no significant difference was found in cVEMP parameters (P13 and N23 latency, threshold, P13-N23 amplitude, and amplitude ratio). The mean amplitudes of P13-N23 showed an increase after caffeine ingestion. However, this was not significant compared with the placebo group (p>0.050). Conclusions: It seems that the extent of caffeine's effects varies for differently evoked potentials. Latency reduction in ABRs indicates that caffeine improves transmission in the central brain auditory pathways. However, different effects of caffeine on auditory- and vestibular-evoked potentials could be attributed to the differences in sensitivities of the ABR and cVEMP tests.